EGFR and non-small cell lung carcinoma: Next, we evaluated the efficacy of Fasudil monotherapy or in combination with gefitinib with respect to the mitigation of EGFR-mutated NSCLC cell proliferation using H1975-cell-line-derived xenograft animal models.